John Frantz

Head of Investor Relations

Equibles does not estimate personal net worth.

Get an email with a short summary when Yarrow Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.

Get YARW alerts

About John Frantz

John Frantz is recorded as Head of Investor Relations at Yarrow Bioscience, Inc. (YARW). John Frantz has spoken on 2 investor events across 1 company, most recently for Yarrow Bioscience, Inc. on July 9, 2025. Yarrow Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Yarrow Bioscience, Inc. includes Rebecca Frey (CEO and Board Member), Bill Lundberg (Chairman and Board Member), Andrew Saik (CFO) and 7 others.

John Frantz on recent calls

“The link to this webcast is on the Investors' page of the Vine Therapeutics corporate website.”

Head of Investor Relations, VYNE Investor Relations Presentation · July 9, 2025

“The link to this webcast is on the Investors' page of the Vine Therapeutics corporate website.”

Head of Investor Relations, VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference · March 20, 2025